Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01052220 · ClinicalTrials.gov registry record · NA

Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention

A NA study of Hypertension and Hemodialysis, sponsored by Wayne State University.

Completed
Registry status
NA
Development phase
118
Enrollment target
2
Study locations

NCT01052220: Completed NA study of Hypertension and Hemodialysis, sponsored by Wayne State University.

NCT01052220 is a NA study of Hypertension and Hemodialysis that has completed, run by Wayne State University. The registered enrollment target is 118 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01052220, a NA study of Hypertension and Hemodialysis, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
NA
Development phase
118 participants
Enrollment target
2
Study locations

Study Summary

The major purpose of this quantitative study is to determine if a 3 month supportive educative nursing intervention incorporating Blood Pressure (BP) education and BP, salt and fluid monitoring, in addition to goal setting and reinforcement will improve BP control in a chronic end-stage renal disease population.

Primary Outcome

Average BPs were calculated from the hemodialysis flow sheets. Pre hemodialysis BPs were averaged to determine BP at baseline, 12 weeks and 16 weeks

Interventions

  • BEHAVIORAL BP education and BP self-regulation
  • BEHAVIORAL Supportive Educative Nursing Intervention

Study Locations (2)

Michigan

  • Davita Detroit Kresge Hemodialysis Unit - Detroit
  • William Beaumont Hemodialysis Units - Royal Oak

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2009-06
Est. Completion 2010-07
Phase NA
Wayne State University

163 total trials

What the finished NCT01052220 record still lists

NCT01052220 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which BP education and BP self-regulation is the first listed.

NCT01052220 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT01052220 about?

NCT01052220 is a clinical study titled "Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention". The major purpose of this quantitative study is to determine if a 3 month supportive educative nursing intervention incorporating Blood Pressure (BP) education and BP, salt and fluid monitoring, in addition to goal setting and reinforcement will improve BP control in a chronic end-stage renal diseas...

What is the current status of trial NCT01052220?

This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2009-06. Estimated completion is 2010-07.

What conditions does trial NCT01052220 study?

This clinical trial studies the following conditions: Hypertension, Hemodialysis.

What interventions are being tested in trial NCT01052220?

The interventions under investigation include: BP education and BP self-regulation (BEHAVIORAL), Supportive Educative Nursing Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01052220?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01052220 being conducted?

This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01052220's enrollment target sits among peer trials

118 273rd of 470 higher than 196 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04040959 · 118 participants · Phase 2

    Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD

  • NCT04696029 · 118 participants · Phase 2

    DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

  • NCT05223192 · 118 participants · NA

    The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants

  • NCT05254327 · 118 participants · Phase 2

    Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01052220, the US trial registry maintained by the National Library of Medicine. NCT01052220 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.